Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04921358
Title Tislelizumab in Combination With Sitravatinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors BeiGene
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Sitravatinib + Tislelizumab

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST